PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Checkpoint Capital L.P.'s Holding History (CIK: 0001977548)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 81,311 Value ($000) $4,494 Avg Close $47.99 Range $39.60 - $57.70

Q1 2025

Shares 175,184 Value ($000) $8,472 Avg Close $41.90 Range $33.70 - $60.60

Q3 2024

Shares 240,000 Value ($000) $10,800 Avg Close $40.40 Range $32.50 - $48.00

Q2 2024

Shares 355,000 Value ($000) $12,301 Avg Close $29.29 Range $24.22 - $35.96

Q1 2024

Shares 280,301 Value ($000) $8,109 Avg Close $27.21 Range $21.43 - $33.34

Q4 2023

Shares 266,856 Value ($000) $6,119 Avg Close $17.50 Range $13.72 - $23.88

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	81,311	$4,494	$47.99	$39.60 - $57.70
Q1 2025	175,184	$8,472	$41.90	$33.70 - $60.60
Q3 2024	240,000	$10,800	$40.40	$32.50 - $48.00
Q2 2024	355,000	$12,301	$29.29	$24.22 - $35.96
Q1 2024	280,301	$8,109	$27.21	$21.43 - $33.34
Q4 2023	266,856	$6,119	$17.50	$13.72 - $23.88